Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study
2015 · BMC Cancer · 23 citations
https://doi.org/10.1186/s12885-015-1309-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
89
Citations
5
h-index
4
i10-index
Ulrich Kube is an academic researcher from Klinikum Chemnitz. The author has contributed to research in topics: Renal cell carcinoma treatment & Cancer Genomics and Diagnostics & Renal and related cancers. The author has an h-index of 5, co-authored 19 publications.
Click to start Chat